Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 620 of 1,261

  1. US 9709703

    Ophthalmic lens material, ophthalmic lens, and method for making the same

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  2. US 9707210

    Methods of treating muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  3. US 9707199

    Heptadecanoic acid supplement to human diet

    United States of America as represented by the Secretary of the Air Force · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  4. US 9708610

    Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

    Ionis Pharmaceuticals, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  5. US 9708392

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  6. US 9708386

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  7. US 9708371

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  8. US 9707230

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  9. US 9708267

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  10. US 9707215

    Inhibitors of hepatitis C virus polymerase

    COCRYSTAL, DISCOVERY, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  11. US 9707206

    Mast cell stabilizers treatment for systemic disorders

    Patara Pharma, LLC · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  12. US 9708296

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  13. US 9707289

    Biochemically stabilized HIV-1 ENV trimer vaccine

    NATIONAL INSTITUTES OF HEALTH (NIH), THE UNITED STATES OF AMERICA DEPT. OF HEALTH AND HUMAN SERVICES (DHHS). · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  14. US 9707262

    Composition with anoxia-tolerant and anti-fatigue effects and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  15. US 9701718

    Adenovirus serotype 26 and serotype 35 filovirus vaccines

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  16. US 9700561

    Drug combinations and uses in treating a coughing condition

    Infirst Healthcare Limited · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  17. US 9701674

    Substituted pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  18. US 9700025

    Genetically modified major histocompatibility complex animals

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  19. US 9700596

    Locally released growth factors to mediate motor recovery after stroke

    The Regents of the University of California · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  20. US 9701713

    Compositions and methods for introduction of macromolecules into cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  21. US 9700628

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  22. US 9700708

    Maintaining multiple defined physiological zones using model predictive control

    The Regents of the University of California · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  23. US 9700491

    One-part dental adhesive

    KURARAY NORITAKE DENTAL INC. · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  24. US 9700509

    Solutions of lipophilic substances, especially medicinal solutions

    Universität Regensburg · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.